Friday turned out to be a nightmare for Cempra Inc (NASDAQ:CEMP) investors after the FDA released nagative briefing documents for CEMP’s Friday Adcom of solithromycin, a …
Cempra, Inc. (NASDAQ:CEMP) announced the receipt of a $10 millionmilestone payment from Toyama Chemical Co.
McKesson Corporation McKesson Corporation (NYSE:MCK) shares are falling nearly 22% today after the company reported disappointing results for the fiscal second-quarter and issued lackluster guidance. MCK posted …
Cempra, Inc. (NASDAQ:CEMP) reported financial results for the quarter ended September 30, 2016 and provided an update on recent corporate developments.
Cempra, Inc. (NASDAQ:CEMP) announced interim results showing anti-NASH effects in the first six nonalcoholic steatohepatitis (NASH) patients dosed with solithromycin in a Phase 2 …
Cempra, Inc. (NASDAQ:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today …
Cempra Inc (NASDAQ:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today …
Cempra, Inc. (NASDAQ:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, …
Cempra Inc (NASDAQ:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, announced …
Cempra Inc (NASDAQ:CAMP), a leading provider of wireless products, services and solutions, today reported results for its fiscal 2017 first quarter ended May 31, …
